News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Oncogene Cancer Research Shares MSK Study on Pre-Surgery Osimertinib in EGFR Lung Cancer
Lung Cancer/X
Jun 9, 2025, 19:08

Oncogene Cancer Research Shares MSK Study on Pre-Surgery Osimertinib in EGFR Lung Cancer

Oncogene Cancer Research — shared on X:

“How do we create better surgical outcomes for early stage EGFR lung cancer as neoadjuvant immuno is not indicated?
MSK Cancer Center shared pre‑surgery osimertinib (w or w/o chemo) led to major tumour shrinkage in EGFR lung cancer at ASCO.”

Read more.

Oncogene Cancer Research referenced new findings from Memorial Sloan Kettering Cancer Center presented at ASCO, showing that pre-surgery osimertinib—with or without chemotherapy—led to significant tumor shrinkage in early-stage EGFR lung cancer where neoadjuvant immunotherapy is not indicated.

Find More Posts Featuring EGFR lung cancer on OncoDaily

cancer EGFR lung cancer OncoDaily Oncogene Cancer Research Oncology
Special Coverage
Oncolibrary
Jul 1, 2025, 12:44
MASCC 2025 Highlights: StrataXRT Prevents Severe Radiation Dermatitis in Large-Breasted Women Undergoing Prone Breast Radiotherapy
Blog
Jul 1, 2025, 10:46
INTERACT-EUROPE 100 Has Launched a New Round of Recruitment - European Cancer Organisation
Societies
Jul 1, 2025, 10:32
25 Posts Not To Miss From MASCC 2025
Blog
Jul 1, 2025, 10:30
Alina Comanescu: Urgent Call to Action - Don't Let Cancer Slip Off the EU Agenda
Blog
Jul 1, 2025, 10:16
Survivor Cindy Pursues Nursing in Ghana Fifteen Years After Kidney Cancer Diagnosis - World Child Cancer
Blog
Jul 1, 2025, 10:07
Treatment Optimisation: Making Cancer Treatment Accessible and Sustainable in Europe - EORTC
Blog
Jul 1, 2025, 09:57
Gevorg Tamamyan: To Me, MD Anderson Has Always Meant Dr. Kantarjian
Career
Jul 1, 2025, 09:56
Sidney Chahonyo is Breaking Barriers as the First Survivor on the Board of Childhood Cancer International
Blog
Jul 1, 2025, 09:34
Jasmine Kamboj: Congratulating the New Co-Leads of the Community of Practice Policy
Dialogues
Jul 1, 2025, 09:27
Top Biotechs at ASCO: Ruthie Davi on AI and Data Insights in Platinum-Resistant Ovarian Cancer
Blog
Jul 1, 2025, 09:25
Alexandre Chan's Final Reflection on MASCC 2025
Dialogues
Jul 1, 2025, 09:21
Women Leaders in Oncology: Nina Mojas on GSK’s Oncology Growth and Innovation Strategy